Federal Supply Schedule 36F79725D017E
Award Date
4/17/25
Last Date to Order
10/14/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Botanix SB Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023.
The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Royal Pharmaceuticals LLC, a foreign-owned for-profit organization. The contract, valued at up to $750,000.00, is for the provision of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule.
The contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2019. It is a multiple-award contract, meaning there...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Bioxcel Therapeutics, Inc. on February 15, 2023. The contract, identified as 36F79723D0071, has a ceiling value of $2,225,000.00 and a period of performance extending to February 14, 2028.
The scope of the contract includes the provision of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA's Veterans Integrated Service Network 12. This indicates that the contract is...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB.
The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027.
The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award...
This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apotex Corp. for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,375,390.00 and a period of performance from September 15, 2024 to September 14, 2029.
As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to directly purchase the awarded products and services. The contract...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Mycovia Pharmaceuticals, Inc. The contract is for Drugs, Pharmaceuticals, & Hematology Related Products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through March 14, 2023. This is a multiple award, non-set-aside contract. The contract aims to procure pharmaceutical and hematology-related...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Noven Therapeutics LLC, a for-profit foreign-owned organization. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $31,335,540.00. The period of performance runs from the award date of October 15, 2020 through the ultimate completion date of October 14, 2025.
The contract is intended to procure a range of pharmaceutical and...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025.
The purpose of the contract is to provide drugs,...